IGI and AbbVie sign licence deal for cancer and autoimmune therapy
Pharmaceutical Technology
JULY 11, 2025
How will RFK Jr’s American dream for vaccines play out? July 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook AbbVie will gain exclusive rights to develop, manufacture and market ISB 2001 across several major regions. Credit: JHVEPhoto/Shutterstock. Don’t let policy changes catch you off guard.
Let's personalize your content